Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
3.685
+0.275 (8.06%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Personalis Employees
As of December 31, 2024, Personalis had 229 total employees, including 228 full-time and 1 part-time employees. The number of employees increased by 4 or 1.78% compared to the previous year.
Employees
229
Change (1Y)
4
Growth (1Y)
1.78%
Revenue / Employee
$369,493
Profits / Employee
-$354,952
Market Cap
324.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
PSNL News
- 1 day ago - Personalis to Announce First Quarter 2025 Financial Results - Business Wire
- 1 day ago - Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection - Business Wire
- 4 weeks ago - Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference - Business Wire
- 7 weeks ago - New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection - Business Wire
- 7 weeks ago - Personalis, Inc. (PSNL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Personalis Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - 3 Biotech/Healthcare Names Under $10 I Am Buying Now - Seeking Alpha
- 2 months ago - Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference - Business Wire